931 related articles for article (PubMed ID: 30157275)
1. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
4. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations.
Tsai WL; Hung CH; Chen HA; Wang JL; Huang IF; Chiou YH; Chen YS; Lee SS; Hung WY; Cheng MF
J Microbiol Immunol Infect; 2018 Dec; 51(6):723-731. PubMed ID: 28927684
[TBL] [Abstract][Full Text] [Related]
6. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Characteristics of Sequence Type 131
Park JY; Yun KW; Choi EH; Lee HJ
Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
[No Abstract] [Full Text] [Related]
8. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
Chung HC; Lai CH; Lin JN; Huang CK; Liang SH; Chen WF; Shih YC; Lin HH; Wang JL
Antimicrob Agents Chemother; 2012 Feb; 56(2):618-22. PubMed ID: 22123694
[TBL] [Abstract][Full Text] [Related]
10. Detection of Escherichia coli Producing CTX-M-1-Group Extended-Spectrum β-Lactamases from Pigs in Aichi Prefecture, Japan, between 2015 and 2016.
Norizuki C; Kawamura K; Wachino JI; Suzuki M; Nagano N; Kondo T; Arakawa Y
Jpn J Infect Dis; 2018 Jan; 71(1):33-38. PubMed ID: 29279444
[TBL] [Abstract][Full Text] [Related]
11. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
[TBL] [Abstract][Full Text] [Related]
12. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China.
Wang S; Zhao SY; Xiao SZ; Gu FF; Liu QZ; Tang J; Guo XK; Ni YX; Han LZ
PLoS One; 2016; 11(1):e0147740. PubMed ID: 26824702
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
[TBL] [Abstract][Full Text] [Related]
15. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
[TBL] [Abstract][Full Text] [Related]
16. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum β-lactamase-producing
Park SY; Kang CI; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Korean J Intern Med; 2017 Jan; 32(1):146-157. PubMed ID: 27093979
[TBL] [Abstract][Full Text] [Related]
18. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
Kang CI; Cha MK; Kim SH; Ko KS; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
J Korean Med Sci; 2013 Jul; 28(7):998-1004. PubMed ID: 23853481
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]